Cargando…
Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies
BACKGROUND AND AIMS: Liver fibrosis is the static and main (70%‐80%) component of portal hypertension (PH). We investigated dynamic components of PH by a three‐dimensional analysis based on correlation of hepatic collagen proportionate area (CPA) with portal pressure (PP) in animals or HVPG in patie...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299647/ https://www.ncbi.nlm.nih.gov/pubmed/34716927 http://dx.doi.org/10.1002/hep.32220 |
_version_ | 1784751022380417024 |
---|---|
author | Königshofer, Philipp Hofer, Benedikt Silvester Brusilovskaya, Ksenia Simbrunner, Benedikt Petrenko, Oleksandr Wöran, Katharina Herac, Merima Stift, Judith Lampichler, Katharina Timelthaler, Gerald Bauer, David Hartl, Lukas Robl, Bernhard Sibila, Maria Podesser, Bruno K. Oberhuber, Georg Schwabl, Philipp Mandorfer, Mattias Trauner, Michael Reiberger, Thomas |
author_facet | Königshofer, Philipp Hofer, Benedikt Silvester Brusilovskaya, Ksenia Simbrunner, Benedikt Petrenko, Oleksandr Wöran, Katharina Herac, Merima Stift, Judith Lampichler, Katharina Timelthaler, Gerald Bauer, David Hartl, Lukas Robl, Bernhard Sibila, Maria Podesser, Bruno K. Oberhuber, Georg Schwabl, Philipp Mandorfer, Mattias Trauner, Michael Reiberger, Thomas |
author_sort | Königshofer, Philipp |
collection | PubMed |
description | BACKGROUND AND AIMS: Liver fibrosis is the static and main (70%‐80%) component of portal hypertension (PH). We investigated dynamic components of PH by a three‐dimensional analysis based on correlation of hepatic collagen proportionate area (CPA) with portal pressure (PP) in animals or HVPG in patients. APPROACH AND RESULTS: Different animal models (bile duct ligation: n = 31, carbon tetrachloride: n = 12, thioacetamide: n = 12, choline‐deficient high‐fat diet: n = 12) and patients with a confirmed single etiology of cholestatic (primary biliary cholangitis/primary sclerosing cholangitis: n = 16), alcohol‐associated (n = 22), and metabolic (NASH: n = 19) liver disease underwent CPA quantification on liver specimens/biopsies. Based on CPA‐to‐PP/HVPG correlation, potential dynamic components were identified in subgroups of animals/patients with lower‐than‐expected and higher‐than‐expected PP/HVPG. Dynamic PH components were validated in a patient cohort (n = 245) using liver stiffness measurement (LSM) instead of CPA. CPA significantly correlated with PP in animal models (Rho = 0.531; p < 0.001) and HVPG in patients (Rho = 0.439; p < 0.001). Correlation of CPA with PP/HVPG varied across different animal models and etiologies in patients. In models, severity of hyperdynamic circulation and specific fibrosis pattern (portal fibrosis: p = 0.02; septa width: p = 0.03) were associated with PH severity. In patients, hyperdynamic circulation (p = 0.04), vascular dysfunction/angiogenesis (VWF‐Ag: p = 0.03; soluble vascular endothelial growth factor receptor 1: p = 0.03), and bile acids (p = 0.04) were dynamic modulators of PH. The LSM‐HVPG validation cohort confirmed these and also indicated IL‐6 (p = 0.008) and hyaluronic acid (HA: p < 0.001) as dynamic PH components. CONCLUSIONS: The relative contribution of “static” fibrosis on PH severity varies by type of liver injury. Next to hyperdynamic circulation, increased bile acids, VWF‐Ag, IL‐6, and HA seem to indicate a pronounced dynamic component of PH in patients. |
format | Online Article Text |
id | pubmed-9299647 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92996472022-07-21 Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies Königshofer, Philipp Hofer, Benedikt Silvester Brusilovskaya, Ksenia Simbrunner, Benedikt Petrenko, Oleksandr Wöran, Katharina Herac, Merima Stift, Judith Lampichler, Katharina Timelthaler, Gerald Bauer, David Hartl, Lukas Robl, Bernhard Sibila, Maria Podesser, Bruno K. Oberhuber, Georg Schwabl, Philipp Mandorfer, Mattias Trauner, Michael Reiberger, Thomas Hepatology Original Articles BACKGROUND AND AIMS: Liver fibrosis is the static and main (70%‐80%) component of portal hypertension (PH). We investigated dynamic components of PH by a three‐dimensional analysis based on correlation of hepatic collagen proportionate area (CPA) with portal pressure (PP) in animals or HVPG in patients. APPROACH AND RESULTS: Different animal models (bile duct ligation: n = 31, carbon tetrachloride: n = 12, thioacetamide: n = 12, choline‐deficient high‐fat diet: n = 12) and patients with a confirmed single etiology of cholestatic (primary biliary cholangitis/primary sclerosing cholangitis: n = 16), alcohol‐associated (n = 22), and metabolic (NASH: n = 19) liver disease underwent CPA quantification on liver specimens/biopsies. Based on CPA‐to‐PP/HVPG correlation, potential dynamic components were identified in subgroups of animals/patients with lower‐than‐expected and higher‐than‐expected PP/HVPG. Dynamic PH components were validated in a patient cohort (n = 245) using liver stiffness measurement (LSM) instead of CPA. CPA significantly correlated with PP in animal models (Rho = 0.531; p < 0.001) and HVPG in patients (Rho = 0.439; p < 0.001). Correlation of CPA with PP/HVPG varied across different animal models and etiologies in patients. In models, severity of hyperdynamic circulation and specific fibrosis pattern (portal fibrosis: p = 0.02; septa width: p = 0.03) were associated with PH severity. In patients, hyperdynamic circulation (p = 0.04), vascular dysfunction/angiogenesis (VWF‐Ag: p = 0.03; soluble vascular endothelial growth factor receptor 1: p = 0.03), and bile acids (p = 0.04) were dynamic modulators of PH. The LSM‐HVPG validation cohort confirmed these and also indicated IL‐6 (p = 0.008) and hyaluronic acid (HA: p < 0.001) as dynamic PH components. CONCLUSIONS: The relative contribution of “static” fibrosis on PH severity varies by type of liver injury. Next to hyperdynamic circulation, increased bile acids, VWF‐Ag, IL‐6, and HA seem to indicate a pronounced dynamic component of PH in patients. John Wiley and Sons Inc. 2021-12-20 2022-03 /pmc/articles/PMC9299647/ /pubmed/34716927 http://dx.doi.org/10.1002/hep.32220 Text en © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Königshofer, Philipp Hofer, Benedikt Silvester Brusilovskaya, Ksenia Simbrunner, Benedikt Petrenko, Oleksandr Wöran, Katharina Herac, Merima Stift, Judith Lampichler, Katharina Timelthaler, Gerald Bauer, David Hartl, Lukas Robl, Bernhard Sibila, Maria Podesser, Bruno K. Oberhuber, Georg Schwabl, Philipp Mandorfer, Mattias Trauner, Michael Reiberger, Thomas Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies |
title | Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies |
title_full | Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies |
title_fullStr | Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies |
title_full_unstemmed | Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies |
title_short | Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies |
title_sort | distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299647/ https://www.ncbi.nlm.nih.gov/pubmed/34716927 http://dx.doi.org/10.1002/hep.32220 |
work_keys_str_mv | AT konigshoferphilipp distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT hoferbenediktsilvester distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT brusilovskayaksenia distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT simbrunnerbenedikt distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT petrenkooleksandr distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT worankatharina distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT heracmerima distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT stiftjudith distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT lampichlerkatharina distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT timelthalergerald distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT bauerdavid distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT hartllukas distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT roblbernhard distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT sibilamaria distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT podesserbrunok distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT oberhubergeorg distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT schwablphilipp distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT mandorfermattias distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT traunermichael distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies AT reibergerthomas distinctstructuralanddynamiccomponentsofportalhypertensionindifferentanimalmodelsandhumanliverdiseaseetiologies |